1 Mortality |
8 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
1.1 Low CVP versus control |
3 |
177 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.36 [0.02, 8.43] |
1.2 Autologous blood donation versus control |
1 |
79 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
1.3 Haemodilution versus control |
2 |
150 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.35 [0.04, 3.32] |
1.4 Haemodilution with controlled hypotension versus control |
1 |
20 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
1.5 Haemodilution with bovine haemoglobin (HBOC‐201) versus haemodilution with hydroxy ethyl starch (HES) |
1 |
12 |
Risk Ratio (M‐H, Fixed, 95% CI) |
3.0 [0.15, 61.74] |
1.6 Hypoventilation versus control |
1 |
79 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
2 Serious adverse events |
5 |
|
Rate Ratio (Fixed, 95% CI) |
0.97 [0.57, 1.65] |
2.1 Autologous blood donation versus control |
1 |
|
Rate Ratio (Fixed, 95% CI) |
0.49 [0.04, 5.32] |
2.2 Haemodilution versus control |
2 |
|
Rate Ratio (Fixed, 95% CI) |
1.01 [0.57, 1.80] |
2.3 Haemodilution with bovine haemoglobin (HBOC‐201) versus haemodilution with hydroxy ethyl starch (HES) |
1 |
|
Rate Ratio (Fixed, 95% CI) |
0.50 [0.05, 5.48] |
2.4 Hypoventilation versus control |
1 |
|
Rate Ratio (Fixed, 95% CI) |
1.95 [0.18, 21.35] |
3 Adverse events (severity unknown) |
4 |
|
Rate Ratio (Fixed, 95% CI) |
1.12 [0.68, 1.85] |
3.1 Low CVP versus control |
2 |
|
Rate Ratio (Fixed, 95% CI) |
0.76 [0.28, 2.03] |
3.2 Haemodilution versus control |
1 |
|
Rate Ratio (Fixed, 95% CI) |
1.38 [0.56, 3.39] |
3.3 Hypoventilation versus control |
1 |
|
Rate Ratio (Fixed, 95% CI) |
1.22 [0.57, 2.62] |
4 Number requiring allogeneic blood transfusion |
8 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
4.1 Low CVP versus control |
3 |
177 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.66 [0.42, 1.03] |
4.2 Autologous blood donation versus control |
1 |
79 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
4.3 Haemodilution versus control |
3 |
233 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.41 [0.25, 0.66] |
4.4 Haemodilution with controlled hypotension versus control |
1 |
20 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.05 [0.00, 0.72] |
4.5 Hypoventilation versus control |
1 |
79 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.73 [0.17, 3.06] |
5 Red cell transfusion |
7 |
|
Std. Mean Difference (IV, Fixed, 95% CI) |
Subtotals only |
5.1 Low CVP versus control |
2 |
135 |
Std. Mean Difference (IV, Fixed, 95% CI) |
‐0.31 [‐0.65, 0.03] |
5.2 Haemodilution versus control |
3 |
180 |
Std. Mean Difference (IV, Fixed, 95% CI) |
‐0.33 [‐0.63, ‐0.03] |
5.3 Haemodilution with controlled hypotension versus control |
1 |
20 |
Std. Mean Difference (IV, Fixed, 95% CI) |
‐3.63 [‐5.16, ‐2.10] |
5.4 Haemodilution with bovine haemoglobin (HBOC‐201) versus haemodilution with hydroxy ethyl starch (HES) |
1 |
12 |
Std. Mean Difference (IV, Fixed, 95% CI) |
0.23 [‐0.91, 1.36] |
5.5 Hypoventilation versus control |
1 |
80 |
Std. Mean Difference (IV, Fixed, 95% CI) |
‐0.12 [‐0.55, 0.32] |
6 Fresh frozen plasma |
|
|
Other data |
No numeric data |
6.1 Low central venous pressure versus control |
|
|
Other data |
No numeric data |
7 Operative blood loss (ml) |
8 |
|
Mean Difference (IV, Fixed, 95% CI) |
Subtotals only |
7.1 Low central venous pressure versus control |
3 |
175 |
Mean Difference (IV, Fixed, 95% CI) |
‐419.35 [‐575.06, ‐263.63] |
7.2 Autologous blood donation versus control |
1 |
79 |
Mean Difference (IV, Fixed, 95% CI) |
‐37.0 [‐100.51, 26.51] |
7.3 Haemodilution versus control |
3 |
128 |
Mean Difference (IV, Fixed, 95% CI) |
‐17.95 [‐67.89, 32.00] |
7.4 Haemodilution with controlled hypotension versus control |
1 |
20 |
Mean Difference (IV, Fixed, 95% CI) |
‐245.00 [‐357.80, ‐136.20] |
7.5 Haemodilution with bovine haemoglobin (HBOC‐201) versus haemodilution with hydroxy ethyl starch (HES) |
1 |
12 |
Mean Difference (IV, Fixed, 95% CI) |
370.0 [‐1103.59, 1843.59] |
8 Operating time (minutes) |
5 |
|
Mean Difference (IV, Fixed, 95% CI) |
Subtotals only |
8.1 Low CVP versus control |
2 |
90 |
Mean Difference (IV, Fixed, 95% CI) |
‐24.69 [‐44.28, ‐5.09] |
8.2 Haemodilution versus control |
2 |
208 |
Mean Difference (IV, Fixed, 95% CI) |
‐28.86 [‐57.37, ‐0.35] |
8.3 Haemodilution with bovine haemoglobin (HBOC‐201) versus haemodilution with hydroxy ethyl starch (HES) |
1 |
12 |
Mean Difference (IV, Fixed, 95% CI) |
23.0 [‐83.60, 129.60] |
9 Hospital stay (days) |
4 |
|
Mean Difference (IV, Fixed, 95% CI) |
Subtotals only |
9.1 Low CVP versus control |
2 |
135 |
Mean Difference (IV, Fixed, 95% CI) |
‐4.53 [‐7.38, ‐1.68] |
9.2 Haemodilution versus control |
1 |
130 |
Mean Difference (IV, Fixed, 95% CI) |
0.0 [‐2.66, 2.66] |
9.3 Haemodilution with bovine haemoglobin (HBOC‐201) versus haemodilution with hydroxy ethyl starch (HES) |
1 |
12 |
Mean Difference (IV, Fixed, 95% CI) |
2.30 [‐7.52, 12.12] |